Global Melanoma Therapeutics Market 2012-2016

Global Melanoma Therapeutics Market 2012-2016

Category : Healthcare

------------ Or -------------

TechNavio's analysts forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.83 percent over the period 2012–2016. One of the key factors contributing to this market growth is the availability of new promising drugs in the pipeline. The Global Melanoma Therapeutics market has also been witnessing the increasing use of combination therapies for the treatment of melanoma. However, the availability of alternative treatment options could pose a challenge to the growth of this market. 

TechNavio's report, the Global Melanoma Therapeutics market 2012–2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Melanoma Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Bristol-Myers Squibb Co., Merck & Co. Inc., and F. Hoffmann-La Roche Ltd.

The other vendors mentioned in the report are AB Science S.A., Amgen Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co. Ltd., GlaxoSmithKline plc, Pfizer Inc., and Vical Inc.

Key questions answered in this report: 
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

 Market Research Process

Research Design

Research Methodology

5. Scope of the Report

Market Overview

Product Offerings

6. Market Landscape

Market Size and Forecast

6.1. Five Force Analysis

7. Melanoma Therapeutics Drugs in Pipeline

8. Geographical Segmentation

9. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis

16.1. Bristol-Myers Squibb Co.

16.1.1. Business Overview

16.1.2. Key Information

16.1.3. SWOT Analysis

16.2. F. Hoffmann-La Roche Ltd.

16.2.1. Business Overview

16.2.2. Business Segmentation

16.2.3. Key Information

16.2.4. SWOT Analysis

16.3. Merck & Co. Inc.

16.3.1. Business Overview

16.3.2. Business Segmentation

16.3.3. Key Information

16.3.4. SWOT Analysis

17. Other Reports in this Series

List of Exhibits:

Exhibit 1:  Market Research Methodology

Exhibit 2:  Global Melanoma Therapeutics Market 2012-2016 (US$ million)

Exhibit 3:  Global Melanoma Therapeutics Market by Geographical Segmentation 2012

Exhibit 4:  Global Melanoma Therapeutics Market by Vendor Segmentation 2012

Exhibit 5:  Business Segmentation of F. Hoffmann-La Roche Ltd.

Exhibit 6:  Business Segmentation of Merck & Co. Inc.

Enquiry Before Buy